Another Major Study Reinforces Angiography-Derived Physiology as a Simpler Path to Optimal PCI Reading time: 5 mins Written on: 30-03-2026 Fast track | European Heart Journal publication of PIONEER IV confirms QFR-guided…
Read MoreLeiden, the Netherlands – February 2nd, 2026 – Medis Medical Imaging, a global leader in AI-powered cardiovascular imaging, today announced the appointment of Kevin DeMoss as VP Commercial QFR –…
Read MoreLeiden, the Netherlands – January 13th 2025 – Medis Medical Imaging, a global leader in advanced AI-powered solutions for cardiovascular imaging, proudly announces the appointment of Regina Beyhl as Head…
Read MoreMadrid, Spain – September 2nd, 2025 – Medis Medical Imaging today announced the interim results of the PIONEER IV trial, presented during the Late-Breaking Clinical Trials session at the European…
Read MoreLeiden, The Netherlands – June 23rd, 2025 – Medis Medical Imaging, a global leader in quantitative imaging solutions for cardiovascular diseases, proudly announces the appointment of Jason Fuller as Vice…
Read MoreLeiden, June 17th, 2025 – Medis Medical Imaging, a global leader in advanced solutions for cardiovascular imaging, proudly announces the appointment of Martijn van Lavieren, PhD as Head of Clinical…
Read MoreLeiden, The Netherlands – May 23, 2025 – Medis Medical Imaging today shares its view on the results of the REPEAT-QFR substudy of FAVOR III Europe, presented by Dr. Sophie…
Read MoreRaleigh, April 7th, 2025 – Medis Medical Imaging, the leading cardiac imaging software company, announces today the FDA clearance of the latest version of its groundbreaking Medis QFR® in the…
Read MoreTerumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), and Medis Medical Imaging, a leading cardiac imaging software company, announced today that they have entered into a strategic partnership, in the United States, to enhance cardiovascular care through the utilization of both ePRISM – Terumo’s proprietary clinical decision support platform – and Medis’ Quantitative Flow Ratio (QFR) technology, a non-invasive software solution designed to assess angiography-derived coronary physiology.
Read MoreMedis’ Quantitative Flow Ratio (QFR®) has been awarded with a Class I recommendation in 3 distinct categories of the 2024 ESC guidelines for the management of patients suffering from chronic coronary syndrome (CCS). This recognition recommends QFR® as a physiology measurement technique next to, and at par with, the traditional wire-based methods. The guidelines also differentiate Medis QFR® from other Angiography-based FFR techniques, which have been called out with a lower IIb/C recommendation, in only one of the 3 categories.
Read More